Literature DB >> 14377278

The use of reserpine in shock-reversible patients and shock-resistant patients.

D C TASHER, M W CHERMAK.   

Abstract

Entities:  

Keywords:  RAUWOLFIA ALKALOIDS/therapeutic use; SCHIZOPHRENIA/therapy; SHOCK THERAPY, ELECTRIC

Mesh：

Substances：

Year:  1955        PMID： 14377278     DOI： 10.1111/j.1749-6632.1955.tb42457.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Some aspects of the effects of acute reserpine treatment on behaviour.

Authors:  P H GLOW
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-02       Impact factor: 10.154

2.  The psychodynamics of the tranquilizing agents.

Authors:  R J SCHMITT
Journal:  Psychiatr Q       Date:  1957-01

3.  The current status of the tranquillizing drugs.

Authors:  P L KURTZ
Journal:  Can Med Assoc J       Date:  1958-02-01       Impact factor: 8.262

4.  A controlled clinical study of chlorpromazine and reserpine in chronic schizophrenia.

Authors:  M SHEPHERD; D C WATT
Journal:  J Neurol Neurosurg Psychiatry       Date:  1956-08       Impact factor: 10.154

5.  Depression in epilepsy: a neurobiologic perspective.

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2005 Jan-Feb       Impact factor: 7.500

6.  [The Rauwolfia alkaloid, reserpine (serpasil) in psychiatry].

Authors:  F A MIELKE
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1956
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.